AUSTIN, Texas — Clinova Solutions today announced the expansion of its longitudinal telehealth model for adults living with recurrent and complex urinary tract infections. Through affiliated medical practices, the model connects patients with licensed clinicians and combines ongoing care management, individualized evaluation, advanced diagnostic options and at-home bladder instillation therapy for clinically appropriate patients.

Recurrent urinary tract infections can be difficult to manage through isolated visits and repeated treatment cycles. Patients may experience persistent symptoms, negative or inconclusive test results, antibiotic-resistant infections or underlying hormonal, microbiome and structural factors that require a more comprehensive evaluation.

Clinova’s model is designed to provide continuity beyond a single consultation. Patients receive an individualized care plan supported by ongoing clinician oversight, follow-up appointments and adjustments based on their symptoms, testing and response to treatment.

For appropriate patients, the care plan may include bladder instillation therapy. This treatment places prescribed medication or solution directly into the bladder through a catheter. Clinova’s at-home program includes patient education, provider instructions, remote monitoring and regular clinical follow-up. Treatment is recommended only after a licensed healthcare provider reviews the patient’s medical history, symptoms, risks and individual clinical needs.

The expanded model is designed to support several populations frequently affected by complex urinary conditions, including women with recurrent UTIs and genitourinary syndrome of menopause, patients with antibiotic-resistant infections and people who use long-term indwelling or suprapubic catheters.

“Our patients don’t have simple UTIs. They have complex, chronic conditions that require a clinician who understands the intersection of microbiology, hormonal health and urology. That’s exactly what Clinova was built to provide,” said Jasmine Bonder, DNP, ACNP-BC, PA-C, founder and CEO of Clinova Solutions.

Clinova’s approach may include evaluation of infectious, microbiome, metabolic or hormonal, autoimmune and structural factors. Advanced diagnostic testing may also be considered when conventional testing does not fully explain persistent or recurring symptoms.

By combining virtual access with longitudinal care and clinician-guided at-home treatment options, Clinova aims to make specialized support more accessible to patients who have struggled to find answers through conventional episodic care.
Patients can visit https://clinova.solutions to learn more or request a consultation.